135 related articles for article (PubMed ID: 15938560)
1. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
Tobin AM; Barragry J; Kirby B; O'Shea L
Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560
[No Abstract] [Full Text] [Related]
2. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
Cherian MP; AbdulJabbar M
Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
[No Abstract] [Full Text] [Related]
3. Unregulated use of clobetasol propionate.
Keane FM; Munn SE; Taylor NF; du Vivier AW
Br J Dermatol; 2001 May; 144(5):1095-6. PubMed ID: 11359411
[No Abstract] [Full Text] [Related]
4. Adrenal suppression following low-dose topical clobetasol propionate.
Ohman EM; Rogers S; Meenan FO; McKenna TJ
J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
[TBL] [Abstract][Full Text] [Related]
5. An infantile Cushing syndrome due to misuse of topical steroid.
Siklar Z; Bostanci I; Atli O; Dallar Y
Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
[TBL] [Abstract][Full Text] [Related]
6. Trichostasis spinulosa: possible association with prolonged topical application of clobetasol propionate 0.05% cream.
Janjua SA; McKoy KC; Iftikhar N
Int J Dermatol; 2007 Sep; 46(9):982-5. PubMed ID: 17822507
[No Abstract] [Full Text] [Related]
7. Evaluation of the effects of topical clobetasol propionate by visual score, electrical impedance and laser Doppler flowmetry.
Emtestam L; Kuzmina N; Talme T
Skin Res Technol; 2007 Feb; 13(1):73-8. PubMed ID: 17250535
[TBL] [Abstract][Full Text] [Related]
8. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
[TBL] [Abstract][Full Text] [Related]
9. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
10. Irrational use of skin-bleaching products can delay the diagnosis of leprosy.
Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM
Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896
[No Abstract] [Full Text] [Related]
11. Cushing syndrome caused by topical corticosteroid: a case report.
Gen R; Akbay E; Sezer K
Am J Med Sci; 2007 Mar; 333(3):173-4. PubMed ID: 17496736
[TBL] [Abstract][Full Text] [Related]
12. Contact allergy to clobetasol propionate.
Cox NH
Arch Dermatol; 1988 Jun; 124(6):911-3. PubMed ID: 2967675
[TBL] [Abstract][Full Text] [Related]
13. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
Semiz S; Balci YI; Ergin S; Candemir M; Polat A
Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
[TBL] [Abstract][Full Text] [Related]
14. Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate.
Young CA; Williams IR; MacFarlane IA
Br J Clin Pract; 1991; 45(1):61-2. PubMed ID: 1931550
[TBL] [Abstract][Full Text] [Related]
15. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
Khalid M; Mujtaba G
Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
[No Abstract] [Full Text] [Related]
16. Adrenal suppression following low-dose topical clobetasol propionate.
Stoughton RB
J R Soc Med; 1988 May; 81(5):308. PubMed ID: 3385719
[No Abstract] [Full Text] [Related]
17. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
Khalid M; Mujtaba G; Haroon TS
Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
[No Abstract] [Full Text] [Related]
19. The pursuit of beauty.
Druce M; Goldstone AP; Tan TM; Meeran K
Lancet; 2008 Feb; 371(9612):596. PubMed ID: 18280330
[No Abstract] [Full Text] [Related]
20. Ingestion of topical steroid triggering pustular psoriasis?
Orpin SD; Hafiji J; Goodyear HM; Salim A
Br J Dermatol; 2005 Sep; 153(3):680-2. PubMed ID: 16120173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
